Quarterly EPS earnings growth: Enzo Biochem (ENZ)

Symbol and logo of brand Enzo Biochem Inc. (ENZ)

Enzo Biochem, Inc. (ENZ) generates revenue through diagnostics and patent monetization, which dictates the quarterly EPS profile. The 51.40 metric reflects current trends resulting from low pricing power amid pressure from insurers. Currently, business resilience depends solely on the outcomes of intellectual property litigation, which has narrowed the company's economic moat.

Enzo Biochem Inc. (ENZ) Year-over-year earnings per share growth for the last 12 months: for the period 07/04/2022 - 04/26/2025

Analytical breakdowns for Enzo Biochem, Inc.

- market value and analyst target forecast:
Price Chart enzo.com|ENZ - Analyst Median Target
- company stock exchange capitalization indicators:
Market Capitalization Enzo|ENZ - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Enzo Biochem|ENZ - Accounting Capitalization|Market Cap to Net Assets Ratio enzo.com|ENZ - Total Asset Value of Company
- company liabilities and liquidity data:
Debt to Equity Enzo Biochem, Inc.|ENZ - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio enzo.com|ENZ - Aggregate Debt Obligations|Debts to Book Capitalization Enzo|ENZ - Company Long-Term Debt|Company Short-Term Debts Enzo Biochem|Quick Liquidity enzo.com
- earnings and market multiples details:
ENZ - Company Net Income|Projected Future Earnings Enzo Biochem, Inc.|ENZ - Price to Earnings Ratio|Forward P/E Multiple enzo.com|ENZ - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Enzo|ENZ - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Enzo Biochem|ENZ - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months enzo.com|ENZ - Earnings per share increase in current year|Earnings growth forecast for next year Enzo Biochem, Inc.
Summary company analytics:Enzo Biochem Inc. - ENZ
Manufactured product of Enzo Biochem

Steady demand for the patented diagnostic reagents and tests of Enzo Biochem, Inc. (ENZ) is reflected in the quarterly EPS growth trend. This metric assesses the efficiency of converting market liquidity into net profit per share, allowing investors to filter out short-term volatility and determine the asset's true fundamental value for a long-term investment consensus.

Direct competitors

Agilent (A) - Year-over-year earnings per share growth for the last twelve months|DGX - Year-over-year net earnings per share change for the last twelve months|ILMN (Illumina Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Exact Sciences Inc. EXAS|Year-over-year earnings per share growth for the last twelve months Revvity, Inc. (RVTY)|bio-rad.com - Year-over-year earnings per share growth for the last 12 months|Anbio - Year-over-year net earnings per share growth for the last 12 months|SHC (Sotera Health Corp) - Year-over-year net earnings per share trend for the last twelve months|QDEL - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months OPKO Health Corp.|CDNA (caredx.com) - Year-over-year net earnings per share growth for the last 12 months|maravai.com - Year-over-year earnings per one share growth for the last 12 months|FLGT (Fulgent Genetics) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months LAB|Quarterly EPS earnings growth CTKB|Year-over-year net earnings per share change for the last twelve months OraSure Corp|Year-over-year earnings per share growth for the last twelve months Exagen XGN|mdxhealth.com (MDXH) - Earnings per share growth in annualized terms for the last twelve months|Lucid Diagnostics - Quarterly EPS earnings growth|Prenetics Global (PRE) - Year-over-year net earnings per share growth for the last 12 months|IMDX: Quarterly EPS earnings growth|Trinity Biotech - Year-over-year earnings per one share growth for the last 12 months|PRPH (ProPhase Labs, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months ainos.com AIMD|Year-over-year earnings per share growth for the last twelve months Co-Diagnostics (CODX)|Year-over-year net earnings per share growth for the last 12 months Heart Test Laboratories, Inc. HSCS|Biomerica, Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months CDIO|Onconetix, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months viraxbiolabs.com VRAX|Bluejay Diagnostics, Inc. (BJDX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months AWH|AXDX (Accelerate Diagnostics, Inc) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months CENTOGENE N.V. (CNTG)|Year-over-year net earnings per share growth for the last 12 months FRES (Fresh2 Group Limited)|Year-over-year net earnings per share change for the last twelve months gtglabs.com|Quarterly EPS earnings growth ME (23andMe)|Psychemedics Corp. (PMD) - Earnings per share growth in annualized terms for the last twelve months